NCT03163368View on ClinicalTrials.gov

Dose Escalation Trial of Neoadjuvant Radiosurgery for the Treatment of Metastatic Brain Tumors

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

May 9, 2017

Primary Completion Date

December 15, 2022

Study Completion Date

November 1, 2025

Conditions
Brain Metastases
Interventions
RADIATION

Neoadjuvant stereotactic radiosurgery

Dose escalation of neoadjuvant stereotactic radiosurgery

PROCEDURE

Neurosurgical resection

Surgical resection of newly diagnosed brain metastases

Trial Locations (1)

90048

Cedars-Sinai Medical Center, Los Angeles

All Listed Sponsors
lead

Cedars-Sinai Medical Center

OTHER

NCT03163368 - Dose Escalation Trial of Neoadjuvant Radiosurgery for the Treatment of Metastatic Brain Tumors | Biotech Hunter | Biotech Hunter